Home / Author / Wealthy Millionaire
Acquisition of largest Phase 1 DMT study conducted to date is expected to accelerate CYB004 program timeline by nine months — — Phase 1 study evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and will inform clinical path forward…
TORONTO — Cybin Inc. (NYSEAMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced the team of 28 esteemed faculty and advisors who will lead the Company’s EMBARK Psychedelic Facilitator Training…
MARKHAM, ON April 28, 2022 / Pond Technologies Holdings Inc. (TSXV:POND)(OTCQB:PNDHF)(FSE: 4O0)(“Pond”), an ESG company addressing global sustainability challenges of wellness and climate change, has entered into a research agreement with BioCarbN Inc. and its development partner Cross…
Gold is making a serious comeback that even the biggest market bears can’t ignore. Investors are realizing that high inflation is here to stay and it‘s created the strongest gold bullion demand in over two decades.¹ U.S. Mint…